Week 8 Update- Elizabeth Holmes/ Theranos Trial Update- Lawyer Reacts

TL;DR

Week eight of the trial revealed damaging testimonies and a jury issue.

Transcript

hi everybody pete sardius here for the laura you know we are back talking about the elizabeth holmes trial fairness week eight it was a short week this week only three days of trial but it was hugely impactful and we're going to talk about those details we also have an update on another jury debacle and we'll talk about that towards the end of this... Read More

Key Insights

• ❓ Testimonies revealed deceptive practices in Theranos demos to influence investors.
• ❎ Pfizer's negative evaluation of Theranos further damaged the company's reputation.
• 🤝 Recorded conversations with Elizabeth Holmes exposed potentially misleading statements about investors and military deals.
• 🤨 A juror being excused for not paying attention raised concerns about the trial process.
• ❓ The trial's duration and potential juror shortage may pose challenges ahead.
• 😵 Cross-examinations and redirecting testimonies played a pivotal role in shaping perceptions.
• 🙂 Thorough evaluations by witnesses like Dr. Shane Weber shed light on the company's credibility issues.

Questions & Answers

Q: What damaging revelations came to light during Daniel Edlund's testimony?

Edlund revealed deceptive practices during demos, where results were manipulated to deceive investors, including Walgreens executives.

Q: How did Dr. Shane Weber's testimony impact the trial?

Weber's testimony highlighted Pfizer's negative evaluation of Theranos, leading to a blow to the company's credibility and showcasing potential deception.

Q: What impact did the excused juror have on the trial proceedings?

The excused juror due to not paying attention raised concerns about the jury's ability to stay focused, potentially affecting the trial outcome.

Summary & Key Takeaways

• Daniel Edlund, a former Theranos project manager, testified about deceptive practices during demos.

• Dr. Shane Weber testified about Pfizer's negative evaluation of Theranos, leading to a damaging blow to the company.

• Juror issue arose as one was excused for not paying attention, posing a potential challenge to the trial.